-
2024中关村论坛年会首届“留学人员创新创业论坛”成功举办
4月27日,2024中关村论坛年会首届“留学人员创新创业论坛”成功举办。本届论坛以“同学同心同力·做新质生产力生力军”为主题,由北京海外联谊会指导,北京市欧美同学
-
百全毫米波治疗仪技术荣获“科学技术成果登记证书”中成康富获国家权威机构认可!
近日,北京中成康富科技股份有限公司(以下简称“中成康富”)创新科技成果“百全毫米波治疗仪技术的研究及应用”荣获由工业和信息化部国家工业信息安全发展研究中心颁
-
东莞少年贵州铜仁寻宝之旅研学营完美结营
五一黄金周期间,由湖南国际频道《奋进吧少年》栏目组织的东莞少年赴贵州铜仁的《东莞少年贵州铜仁寻宝之旅研学营》,开展了为期五天四夜的研学旅程。 在距今有
-
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium
Equinor Commits to Contribute up to a US$160 million Gross Investment for a 45% interest in two special purpose entities with SLI to develop a susta
-
墨海融情·精益求精——书法名家梁宜君百家媒体聚焦报道
梁宜君,1959年生,籍贯江苏常州,住地广东佛山, 中国书法家协会会员,西班牙皇家艺术协会国际会员,全国艺术职称考级中心首席专家,中国文旅部特邀篇委成员,中华国礼艺术家,
-
Novotech 发布精准肿瘤学格局白皮书,指出靶向治疗的当前趋势和机遇
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech 是一家提供全方位服务的全球性临床合同研究组织 (CRO),它与生物技术公司合作,加速各个阶段先进和新颖疗法的
-
Novotech 发布有关血脂异常和非小细胞肺癌全球临床试验概况的新报告
波士顿, May 09, 2024 (GLOBE NEWSWIRE) -- Novotech,一家以亚太地区为中心、具有全球执行能力的领先生物技术临床合同研究组织 (CRO) 于今日发布了关于血脂异
-
AB InBev Reports First Quarter 2024 Results
Consistent execution of our strategy delivered a 5.4% EBITDA increase with margin expansion, and 16% Underlying EPS growth Anheuser-Busch InBev (Brus
-
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in F
Galderma has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with mode
-
QVC Signs Multi-Year Contract Extensions with SES in Germany and the UK
Worldwide leader in video commerce extends long-standing partnership to continue broadcasting multiple HD and SD channels from SES’s prime 19.2 degre
-
INRED and SES to Provide High-Throughput Connectivity Across Colombia’s Amazonas
The Amazonas Digital initiative will see INRED leverage SES’s MEO satellites in Colombia to connect more than 500 homes, schools and government entit
-
SES to acquire Intelsat: Investor Relations Frequently Asked Questions
LUXEMBOURG--(BUSINESS WIRE)--SES S.A.: 1) What is the rationale of the transaction? What is the benefit for SES shareholders? This combination crea